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Abstract 
Medical device designs aspire to take into account human factors and ergonomics. However, making these designs affordable and 
appropriate for developing nations is often challenging, especially when the accepted product cost has to be low. In this paper a 
theoretical model is presented to explore how creating appropriate designs for developing countries is more challenging than for 
developed countries. For illustrative purposes the model will take in variables that represent real-world descriptors. The variables 
relate to functionality, comfort and cost of a certain product. The outcome will describe the appropriateness of the final design. 
All the variables involved in the design can be assumed to have a certain number of degrees of freedom. These degrees of 
freedom are the number of independent ways by which the design can change without violating constraints that are imposed on it. 
In other words it is the number of dimensions in the design domain. The domain is more limited in the developing world and this 
is caused by the restricted product cost. A design threshold is subsequently set to compute the total volume of acceptable designs 
within a certain domain. A discrete computation method is used to estimate this volume. The model shows that the number of 
appropriate designs increases with almost a factor 5 when the accepted cost are doubled, increasing the probability on developing 
an appropriate medical device that correctly takes into account human factors and ergonomics. Relative to the total design 
volume, the percentage of acceptable designs drops from 34% to 6% when the allowed cost are halved. These results represent an 
abstraction of the appropriateness of designs, based on the interaction of selected variables. The model itself will produce 
different outcomes depending on the parameters that are set. Further verification and validation is needed to assess which values 
best represent real-world conditions. 
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1. Introduction 
Developing medical devices that are appropriate for a local community can yield very contrasting designs in 
different parts of the world. This is because user requirements are locally driven and they are usually rooted in the 
socio-economic status of the users. The person's perception, cultural background, economic conditions and political 
climate are some of the key factors that not only drive risk assessment [1], but often also the acceptance of new 
designs. Design itself can be defined as “a specification of an object, manifested by some agent, intended to 
accomplish goals, in a particular environment, using a set of primitive components, satisfying a set of requirements, 
subject to some constraints” [2]. This definition provides a construct that relates to a range of objects including less 
obvious items, such as policies or laws. Although, the definition given by [2] does not state the design process that is 
followed, it does provide clarity in terms of variables that play a role in the design. In this paper we are looking at 
physical artefacts that interact with one or more persons within a medical context.  
The design for medical devices is different compared to other devices, as the final product has to comply with 
additional rules and regulations. Despite these additional requirements, medical device design frequently follows a 
set of predetermined phases [3] that show considerable overlap with generic design practices. The process can 
consist of defining the initial product concept, the stakeholders and the objective of a particular design. A feasibility 
study can then be conducted to evaluate the possibility of the proposed idea. At this stage it is advisable to 
incorporate user needs and preferences in order to define design criteria that are relevant within the clinical field [4, 
5]. Data regarding needs and preferences can be obtained through e.g. observations, diaries, surveys, interviews, 
focus groups, published information or a combination of these. The final selection of requirements need to be 
testable, to allow for verification and validation throughout the development cycle.  These requirements can be split 
into functional, performance and interface provisions [3]. Functional aspects focus on what the device does and the 
operations it conducts, while performance can be measured in variables such as speed, accuracy and durability. The 
interface component describes how the design interfaces with the external world. However, a range of different 
models of design can be applied to complete the process [6]. 
In this paper we focus on an abstract description of design, with the aim to provide a conceptual model that can be 
used to explore how creating designs in developing countries can be more challenging than in developed countries. 
For clarity we will only integrate performance variables and total cost at this stage. 
2. Modelling the appropriate design domain 
2.1. Structure 
All the variables involved in the design can be assumed to have a certain degree of freedom. These degrees of 
freedom are the number of independent ways by which a dynamic system can move without violating the constraints 
that are imposed on it (e.g. allowed product cost). In other words it is the number of dimensions of the domain. 
We can write down the case of three dimensions in a particular domain as 
  , , , ,x y z x y z              (1) 
 
We assume this domain to be a rectangular prism with 
 
a x b c y d e z fd d d d d d          (2) 
 
We than describe a simple linear function for which all outcomes within the domain are given by    
   ^ `, , , , 0f x y z px qy rz k p q r      z        (3) 
 
p, q, r are the partial slopes of the function and k denotes the intercept. The partial slopes can also be interpreted 
as weighing factors for the different dimensions. The outcome f(x,y,z) represents a single measure for acceptability 
of the final product design.  
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Fig. 1. Top plot shows model 1 for g and bottom shows g/2 in which all units are arbitrary. 
Let (x,y,z) represent real-world descriptors for a certain product, such as maintenance, robustness and cost, for 
which low values indicate lower robustness and cost, but greater maintenance. The cost (z) will represent the overall 
cost of the product. The value (k) is the summed value of all other design features that are relevant for the overall 
design and have not been considered as separate values within the model. All values will be given in arbitrary units 
(A.U.). 
In this first model we assume (x,y,z) to be independent. The following parameter values were set 
 
0,  2,  0,  2,  0,  2,  2,  2,  .5,  1a b c d e g p q r k             (4) 
 
This model was run with a maximum product cost of g and g/2. The maximum cost represents the upper bound of 
the product that is being designed. The results are shown in Fig. 1.  
If an acceptable design is defined by then the total volume of acceptable designs within the domain can be 
computed. A discrete computation method is used to estimate the volume by separating the domain in cubic blocks 
with a given size of s3 with s=.1. All blocks containing a value above the aforementioned threshold, which was set 
in equation 5, are summed providing an estimate of the total volume of acceptable designs. 
  , , 2f x y z !           (5) 
  
The situation described in the top plot of Fig. 1 shows a volume of 7.2600 A.U.3 of acceptable designs from an 
entire volume of 8.000 A.U.3 possible designs available. The bottom plot has been limited to a product cost of g/2 
and this only yields 3.7320 appropriate designs.  
However, this first model generates an optimal product design at zero cost and it also assumes that the quality of 
the product properties has no relation to cost. The following equation was set to simulate a dependency on cost.  
          , , ln ln lnf x y z z x z x rz z k           (6) 
 
The assumed logarithmic pattern relies on the notion that a commercial product will cost some money and 
therefore no or unrealistic low costs should never yield any representative product designs. This is reflected in the 
fact that any medical device design will include certain aspects that are required in order to be regarded as a product 
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and these include e.g. manufacture, assembly and quality assurance. Within these basic phases cost will initially play 
an important role, as an increase from 0.1 to 0.2 A.U. will mean a doubling of the product cost, while at the higher 
regions the same absolute increase from 1.0 to 1.1 only indicates a 10% rise. The effect of cost is therefore likely to 
be greater at the lower regions and it should tail off once it starts to fall outside the main consumer budget (including 
financial schemes that are available for purchase). Theoretically this would suggest a non-linear function and the 
logarithmic form seems like an appropriate candidate for this conceptual model. The outcomes of this model are 
displayed in Fig. 2.   
This second model shows that no appropriate design is feasible at zero cost, as no product can be generated at 
that cost level. However, it is clear that in this second model cost is the only driver of acceptable design. It is known 
that product cost is not the only driver for acceptance [7, 8].  
A third model that fuses both previous models together should provide a more realistic approach and this model 
can be described as   
   
       ln ln ln, ,
2 2 2
z x px z y qy z k k
f x y z rz
          (7) 
 
The third model shows that lower cost are preferential when maintenance and robustness have gained acceptable 
levels (see Fig. 2).    
 
Fig. 2. Top plot shows model 2 for g and bottom shows g/2 in which all units are arbitrary. 
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Fig. 3. Top plot shows model 3 for g and bottom shows g/2 in which all units are arbitrary. 
This model yields a volume of 2.7270 A.U.3 appropriate designs when cost is set to go up to g, but the volume of 
acceptable designs diminishes to only 0.4810 A.U.3 for g/2. The number of appropriate designs increases with 
almost a factor 5 when the accepted cost are doubled. Relative to the total design volume of 8.000 A.U.3 the 
percentage of acceptable designs drops from 34% to 6% when the allowed cost are halved. 
3. Discussion 
These results represent an abstraction of the appropriateness of designs, based on the interaction of selected 
variables. The model itself will produce different outcomes depending on the parameters that are set and the selected 
values are only place holder at this initiation stage of the conceptual model. This explorative model is meant to 
provide a first step towards the development of quantitative models that will help to further understand the 
difference that exist between developing and developed worlds in terms of design challenges. The model can be 
described as a conceptual system that can be further developed to explain the emergence of appropriate designs 
under different circumstances. The final model shows that the domain space of appropriate designs might be 
severely limited when overall cost is a factor 2 lower.      
According to the United Nations Conference on Trade and Development  secretariat calculations [9] the average 
gross domestic product per capita is $3703 for developing economies and $39445 for developed economies 
highlighting some of the potential discrepancies between the acceptable product cost. Medical device spending per 
capita in 2013 was as low as $2 for countries such as India and Indonesia, while the USA and Switzerland spent 
over $350 per capita [10]. Designs can become more complex with increasing costs, but higher costs also allow for a 
wider range of solutions for key issues that can prevent a product from becoming successful. At the same time 
projects that make losses tend to involve a narrow, often styling-oriented, approach to design with more attention 
paid to cost reduction than to performance, quality and innovation [11]. Cost reduction becomes a more important 
aspect of the development cycle when total cost is required to be low. This makes it harder to design-to-cost and 
thus can make it more challenging to create appropriate designs in the developing world.   
It has also been shown that on average 38% of medical equipment that has been donated to developing countries 
became out of service [12]. The threshold set in equation 5 might therefore be even higher for developing countries, 
due to a more stringent requirement in terms of robustness and maintenance. The combination of all these challenges 
reduces the "appropriate design" domain for developing countries. Further verification and validation of these kind 
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of models is needed to relate them to real world scenarios, including the integration of empirical probability 
distributions to improve the validity of the model. More data needs to be generated to verify these proposed models.   
Often low-cost and durable technology is regarded as appropriate, but discrepancies are present to what is truly 
appropriate within the developing world [13]. There is much progress that can be made within the field of 
appropriate and affordable design, which makes it ideally suited for academic exploration. This work is a first 
attempt to generate quantitative models to define the intrinsic issues that are faced with understanding the challenges 
for appropriate design. 
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